Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

This cross-sectional study examines whether proposed myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) diagnostic criteria can exclude other diseases, such as multiple sclerosis, and rely on results of cell-based assays.

Detalles Bibliográficos
Autores principales: Lipps, Patrick, Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Mutke, Matthias Anthony, Kuhle, Jens, Papadopoulou, Athina, Pröbstel, Anne-Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565644/
https://www.ncbi.nlm.nih.gov/pubmed/37814961
http://dx.doi.org/10.1001/jamaneurol.2023.3956
Descripción
Sumario:This cross-sectional study examines whether proposed myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) diagnostic criteria can exclude other diseases, such as multiple sclerosis, and rely on results of cell-based assays.

Ejemplares similares